Wednesday, October 06, 2004

From The Globe and Mail:
Death of a Wonder Drug
It was nicknamed a "super Aspirin" when it hit the market five years ago, billed as an early blockbuster of the biotech era, a remarkably safe anti-inflammatory drug and painkiller bound to be a hit with aging baby boomers.

Merck & Co. Inc. first developed Vioxx as a new class of arthritis medication. But it quickly landed in medicine cabinets as a treatment for everything from muscle aches to menstrual cramps, with 3.4 million prescriptions filled in Canada last year, and 84 million people taking it around the world.

No comments: